Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus

J Am Soc Nephrol. 1998 Sep;9(9):1664-9. doi: 10.1681/ASN.V991664.

Abstract

Nephropathy is a frequent complication of long-term diabetes. Strong evidence exists that genetic predisposition plays a major role in the development of diabetic nephropathy. The role of the angiotensin I-converting enzyme gene (ACE) in the susceptibility to nephropathy in diabetes, especially in non-insulin dependent diabetes mellitus (NIDDM), remains unclear. This study examines the association of two ACE polymorphisms: a 287-bp insertion/deletion (I/D) in intron 16 and PstI (A/G substitution in intron 7; alleles P/M) with renal complications in 941 NIDDM patients. From this group, for further analysis 127 patients were selected with overt proteinuria or chronic renal failure, 335 patients with microalbuminuria, and a control group of 254 normoalbuminuric patients with a diabetes duration of at least 10 yr. No significant differences in the distribution of ACE I/D and PstI genotypes or allele frequencies were observed between the examined groups. The results of this study strongly suggest that there is no association between the ACE gene I/D and PstI polymorphisms and nephropathy in NIDDM.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Albuminuria / genetics
  • Alleles
  • Analysis of Variance
  • Base Sequence
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetic Nephropathies / enzymology
  • Diabetic Nephropathies / genetics*
  • Female
  • Genetic Markers
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Peptidyl-Dipeptidase A / genetics*
  • Peptidyl-Dipeptidase A / metabolism
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Reference Values
  • Sensitivity and Specificity

Substances

  • Genetic Markers
  • Peptidyl-Dipeptidase A